GRAIL, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
GRAIL, Inc. (GRAL) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $208.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-06
- GRAIL, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $5.57M.
- GRAIL, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$5.36M.
- GRAIL, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $5.56M.
- GRAIL, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $9.37M, a 41.68% decline year-over-year.
- GRAIL, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $6.46M.
- GRAIL, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$12.92M, a 649.38% decline from fiscal 2023.
- GRAIL, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $2.35M, a 79.66% decline from fiscal 2023.
- GRAIL, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $11.56M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $208.00K 10-Q · filed 2026-08-06 | $5.77M derived: sum of 3 quarters · filed 2026-08-06 | $15.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$5.36M 10-Q · filed 2026-05-07 | $198.00K derived: sum of 2 quarters · filed 2026-05-07 | $9.57M derived: sum of 3 quarters · filed 2026-05-07 | $4.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $5.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $14.94M derived: sum of 2 quarters · filed 2026-03-12 | $9.56M derived: sum of 3 quarters · filed 2026-08-06 | $6.46M 10-K · filed 2026-03-12 |
| 2025-09-30 | $9.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.00M derived: sum of 2 quarters · filed 2026-08-06 | $894.00K 10-Q · filed 2025-11-13 | -$13.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$5.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$8.48M 10-Q · filed 2026-08-06 | -$23.19M derived: sum of 3 quarters · filed 2026-08-06 | -$7.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$3.10M 10-Q · filed 2026-05-07 | -$17.81M derived: sum of 2 quarters · filed 2026-05-07 | -$1.74M derived: sum of 3 quarters · filed 2026-05-07 | -$14.91M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$14.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.37M derived: sum of 2 quarters · filed 2026-03-12 | -$11.80M derived: sum of 3 quarters · filed 2026-03-12 | -$12.92M 10-K · filed 2026-03-12 |
| 2024-09-30 | $16.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.91M derived: sum of 2 quarters · filed 2025-11-13 | $1.79M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$13.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$14.28M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$1.11M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $2.35M 10-K · filed 2025-03-05 | |||
| 2023-01-01 | $11.56M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |